| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
163,573 |
143,357 |
$22.20M |
| 59425 |
|
11,254 |
7,208 |
$945K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,021 |
7,792 |
$362K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,953 |
6,864 |
$291K |
| 99215 |
Prolong outpt/office vis |
1,659 |
1,647 |
$254K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
147,533 |
133,229 |
$242K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,704 |
3,684 |
$203K |
| 90686 |
|
8,981 |
8,855 |
$166K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,971 |
1,962 |
$153K |
| 92551 |
|
5,773 |
5,735 |
$122K |
| 90670 |
|
4,258 |
4,173 |
$117K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,915 |
3,862 |
$116K |
| 90715 |
|
2,871 |
2,865 |
$94K |
| 98960 |
|
2,230 |
1,933 |
$89K |
| 90739 |
|
684 |
684 |
$83K |
| 90651 |
|
1,359 |
1,352 |
$83K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
3,902 |
3,269 |
$72K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,207 |
2,172 |
$71K |
| G9920 |
Screening performed and negative |
1,625 |
1,623 |
$70K |
| 90677 |
|
459 |
457 |
$68K |
| 90750 |
|
382 |
381 |
$66K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,234 |
3,095 |
$66K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16,983 |
16,532 |
$59K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
2,299 |
2,298 |
$56K |
| J3490 |
Unclassified drugs |
677 |
660 |
$52K |
| 90716 |
|
1,530 |
1,478 |
$49K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,080 |
972 |
$46K |
| 90648 |
|
3,318 |
3,240 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,942 |
7,806 |
$43K |
| 59430 |
|
500 |
497 |
$41K |
| 99173 |
|
5,607 |
5,570 |
$38K |
| 90680 |
|
2,536 |
2,534 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,879 |
3,847 |
$34K |
| 90688 |
|
1,718 |
1,716 |
$33K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
2,685 |
2,101 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
561 |
561 |
$32K |
| 90723 |
|
2,285 |
2,272 |
$31K |
| 85018 |
|
13,387 |
13,017 |
$30K |
| 90633 |
|
2,167 |
2,061 |
$30K |
| 90707 |
|
1,281 |
1,237 |
$25K |
| 99401 |
|
1,235 |
1,216 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
667 |
657 |
$20K |
| 96156 |
|
1,057 |
1,021 |
$20K |
| 81025 |
|
5,817 |
5,635 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
137 |
137 |
$16K |
| 90746 |
|
226 |
226 |
$16K |
| 90697 |
|
825 |
824 |
$15K |
| 99205 |
Prolong outpt/office vis |
167 |
167 |
$15K |
| 90734 |
|
813 |
812 |
$14K |
| 90656 |
|
573 |
572 |
$14K |
| 87428 |
|
224 |
223 |
$14K |
| 58300 |
|
148 |
75 |
$14K |
| 82947 |
|
3,562 |
3,384 |
$13K |
| 90700 |
|
842 |
818 |
$12K |
| 81002 |
|
6,299 |
5,739 |
$11K |
| 90732 |
|
95 |
95 |
$11K |
| 99381 |
|
126 |
126 |
$10K |
| 90662 |
|
151 |
151 |
$10K |
| 97802 |
|
380 |
380 |
$9K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
12 |
12 |
$9K |
| 99490 |
Ccm add 20min |
40 |
40 |
$7K |
| 90710 |
|
404 |
399 |
$7K |
| 90696 |
|
416 |
412 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
659 |
656 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
727 |
725 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
410 |
410 |
$6K |
| H0049 |
Alcohol and/or drug screening |
165 |
165 |
$6K |
| 83655 |
|
415 |
415 |
$6K |
| 96150 |
|
170 |
170 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
212 |
208 |
$4K |
| 99000 |
|
1,108 |
1,045 |
$4K |
| 99188 |
|
159 |
159 |
$4K |
| 90681 |
|
195 |
195 |
$3K |
| 99384 |
|
25 |
25 |
$3K |
| S9452 |
Nutrition classes, non-physician provider, per session |
200 |
193 |
$2K |
| 86580 |
|
517 |
513 |
$2K |
| 88720 |
|
452 |
403 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
50 |
50 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
19 |
19 |
$1K |
| 97803 |
|
117 |
113 |
$1K |
| 90658 |
|
62 |
62 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,213 |
1,134 |
$1K |
| 96158 |
|
102 |
102 |
$1K |
| 90673 |
|
18 |
18 |
$1K |
| 87210 |
|
288 |
287 |
$1K |
| 90674 |
|
80 |
80 |
$1K |
| 90619 |
|
33 |
33 |
$775.50 |
| A4267 |
Contraceptive supply, condom, male, each |
201 |
200 |
$751.80 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
14 |
$478.98 |
| 90685 |
|
33 |
33 |
$471.04 |
| 96152 |
|
29 |
27 |
$345.50 |
| 81003 |
|
123 |
116 |
$245.62 |
| 93000 |
|
37 |
37 |
$154.73 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
195 |
172 |
$99.20 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
2,706 |
2,483 |
$79.83 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
27 |
$62.33 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
104 |
100 |
$22.25 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
31 |
31 |
$3.25 |
| Z6400 |
|
1,442 |
1,255 |
$0.00 |
| Z6304 |
|
88 |
88 |
$0.00 |
| Z6414 |
|
740 |
633 |
$0.00 |
| Z6200 |
|
129 |
128 |
$0.00 |
| 99442 |
|
152 |
150 |
$0.00 |
| Z6300 |
|
178 |
177 |
$0.00 |
| 99499 |
|
293 |
291 |
$0.00 |
| Z6208 |
|
41 |
41 |
$0.00 |
| Z6308 |
|
62 |
58 |
$0.00 |
| Z6402 |
|
99 |
99 |
$0.00 |
| Z1032 |
|
833 |
824 |
$0.00 |
| Z6406 |
|
88 |
88 |
$0.00 |
| Z1034 |
|
9,404 |
6,860 |
$0.00 |
| Z6410 |
|
493 |
406 |
$0.00 |
| Z6204 |
|
88 |
88 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
21 |
21 |
$0.00 |